173 related articles for article (PubMed ID: 29337058)
21. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
22. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
[TBL] [Abstract][Full Text] [Related]
23. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
Xu X; Yan Q; Wang Y; Dong X
Oncol Rep; 2017 Jan; 37(1):449-457. PubMed ID: 27840993
[TBL] [Abstract][Full Text] [Related]
24. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
25. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
[TBL] [Abstract][Full Text] [Related]
26. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.
Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E
Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648
[TBL] [Abstract][Full Text] [Related]
27. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
28. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
29. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.
Yu L; Yang Y; Hou J; Zhai C; Song Y; Zhang Z; Qiu L; Jia X
Oncol Rep; 2015 Oct; 34(4):1845-52. PubMed ID: 26252024
[TBL] [Abstract][Full Text] [Related]
31. SMARCAD1 knockdown uncovers its role in breast cancer cell migration, invasion, and metastasis.
Al Kubaisy E; Arafat K; De Wever O; Hassan AH; Attoub S
Expert Opin Ther Targets; 2016 Sep; 20(9):1035-43. PubMed ID: 27232533
[TBL] [Abstract][Full Text] [Related]
32. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
33. Role of Carboxypeptidase N Invasion and Migration in Breast Cancer.
Cui R; Zhang P; Li Y
Anticancer Agents Med Chem; 2016; 16(9):1198-202. PubMed ID: 26860443
[TBL] [Abstract][Full Text] [Related]
34. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
[TBL] [Abstract][Full Text] [Related]
35. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
36. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
[TBL] [Abstract][Full Text] [Related]
37. p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
Li SS; Xu LZ; Zhou W; Yao S; Wang CL; Xia JL; Wang HF; Kamran M; Xue XY; Dong L; Wang J; Ding XD; Bella L; Bugeon L; Xu J; Zheng FM; Dallman MJ; Lam EWF; Liu Q
Carcinogenesis; 2017 Oct; 38(11):1092-1103. PubMed ID: 28968743
[TBL] [Abstract][Full Text] [Related]
38. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
39. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
40. BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Zhang Y; Li M; Zhao L; Chen J; Yang S; Zhang X
Oncol Rep; 2016 Mar; 35(3):1823-30. PubMed ID: 26751737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
